TNFRSF11B and aortic valve disorder: Tissue from Older mice was used to study the impact of OPG treatment upon factors putatively involved in valve dysfunction: valve calcification, fibrosis, lipid accumulation, and also upon mechanisms by which aortic valve disease may progress: inflammation and oxidant stress.